Internet-delivered Cognitive Behaviour Therapy for Older Adults With Anxiety

Depression Clinical Trial

Official title:

Individually-tailored Internet-delivered Cognitive Behaviour Therapy Treatment for Older Adults With Anxiety and Depression: a Randomized Controlled Trial

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT02403557
• Other study ID #: GA-Forte-Older-Adults-Anx
• Status: Completed
• Phase: N/A
• First received: March 26, 2015
• Last updated: March 1, 2016
• Start date: February 2012
• Est. completion date: December 2015

Study information

• Verified date: March 2016
• Source: Linkoeping University
• Contact: n/a
• Is FDA regulated: No
• Health authority: Sweden: Regional Ethical Review Board
• Study type: Interventional

Clinical Trial Summary

The purpose of this study is to determine whether tailored internet-administrated cognitive behaviour therapy (ICBT) is a feasible approach in the treatment of anxiety symptoms and comorbid depressive symptoms in older adults.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 66
• Est. completion date: December 2015
• Est. primary completion date: December 2015
• Accepts healthy volunteers: No
• Gender: Both
• Age group: 60 Years and older

Eligibility

Inclusion Criteria:

• Have anxiety symptoms

Exclusion Criteria:

• Suicidal ideation

• Alcohol addiction

• Other major primary psychiatric disorder

• Ongoing psychological treatment

Study Design

Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment

Related Conditions & MeSH terms

• Anxiety
• Anxiety Disorders
• Depression

Intervention

Behavioral:
• Waitlist
Weekly check up.
• Tailored Internet-delivered CBT
Tailored Internet-delivered CBT during 8 weeks.

Locations

Country	Name	City	State
n/a

Sponsors (1)

Lead Sponsor	Collaborator
Linkoeping University

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Beck Anxiety Inventory (BAI)	Change from baseline in symptoms two weeks post treatment and at 12 months post treatment.	Two weeks pre treatment, two weeks post treatment and 12 months post treatment	No
Secondary	Patient Health Questionnaire (PHQ)	Change from baseline in symptoms two weeks post treatment and at 12 months post treatment.	Two weeks pre treatment, two weeks post treatment and 12 months post treatment	No
Secondary	The Generalized Anxiety Disorder 7-item Scale (GAD-7)	Change from baseline in symptoms two weeks post treatment and at 12 months post treatment.	Two weeks pre treatment, two weeks post treatment and 12 months post treatment	No
Secondary	Quality of Life Inventory (QOLI)	Change from baseline in symptoms two weeks post treatment and at 12 months post treatment.	Two weeks pre treatment, two weeks post treatment and 12 months post treatment	No
Secondary	Montgomery Åsberg Depression Rating Scale - Self Rated (MADRS-S)	Change from baseline in symptoms two weeks post treatment and at 12 months post treatment.	Two weeks pre treatment, two weeks post treatment and 12 months post treatment	No
Secondary	Clinical Outcome in Routine Evaluation - Outcome Measure (CORE-OM)	Change from baseline in symptoms two weeks post treatment and at 12 months post treatment.	Two weeks pre treatment, two weeks post treatment and 12 months post treatment	No
Secondary	Cognitive Failures Questionnaire (CFQ)		Two weeks pre treatment, two weeks post treatment and 12 months post treatment	No
Secondary	Wisconsin Card Sorting Test-64 (WCST-64)		Two weeks pre treatment, two weeks post treatment and 12 months post treatment	No